Home » Newsletters » BioWorld Science

BioWorld Science

July 28, 2000

View Archived Issues

MedImmune reports significant progress during second quarter

Acetylcysteine useful in preventing contrast agent-induced reductions in renal function

IB-367 active against microflora associated with oral mucositis

Sitaxsentan causes selective pulmonary vasodilatation in chronic heart failure

Antiviral action of aciclovir lipid prodrug assessed against woodchuck hepatitis virus

Atrix rapidly enrolls patients in clinical trials

Phase II SBIR grant awarded to Aurora for immunomodulatory drug discovery

Potent new inhibitor of p210Bcr-Abl tyrosine kinase with selectivity for Bcr-Abl-positive leukemia

Novel cell adhesion inhibitor acting independently of NF-kappaB identified by Kowa

TxA2 antagonism and antiplatelet effects of new torasemide derivative BM-531

Alza, Crescendo report substantial progress this year

Trial in healthy subjects confirms safety and pharmacological effects of TF-505

New immunomodulator promising for the management of HIV/AIDS

Bexxar enters phase II trial for intermediate-grade NHL

VRCTC-310-Onco enhances serum antiinflammatory cytokine production in humans

Maxygen and Karolinska Institute to develop novel allergy therapeutics

Cubist ready to commence further phase III trials of Cidecin

Pharmacia drops leridistim research program

TNF-alpha inhibitors and use in therapy of joint inflammation, asthma

New dosage form, indication approved for Bayer's cerivastatin

Promising phase Ib results shown for Isotechnika's ISAtx-247

Recently issued patent covers new nicotinic acetylcholine receptor antagonists

AstraZeneca presents novel antiinflammatory compounds for asthma, etc.

Nonpeptide GLP-1 antagonists and their potential uses described in recent patent

Novel classes of calcium-activated SK/IK/BK channel modulators designed at NeuroSearch

New inhibitors of Ras oncogene farnesylation in the Merck pipeline

Antex evaluates dosing schedule in phase Ib/II trial of Helivax

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...